stage 3a nonsmall cell lung cancer survival rate
Báo cáo khoa học: "Large volume unresectable locally advanced nonsmall cell lung cancer: acute toxicity and initial outcome results with rapid arc" potx
Ngày tải lên :
09/08/2014, 09:20
... late toxicity.
Background
Lung cancer remains the major cause of cancer- related
mortality worldwide. Non-small cell lung cancer
(NSCLC) account for at least 80% of all lung tumors
and about 30% ... advanced lung cancer (stage III) with volumetric modulated arcs using RapidArc (RA).
Methods: Twenty-four consecutive patients were treated with RA. All showed locally advanced non-small cell lung
cancer ... a 2-year local control and overall survival of
58% and 58% respectively and a median survival time of
25 months for patients with inoperable stage III lung
cancer and treated with 70 Gy (range...
- 9
- 265
- 0
Báo cáo khoa học: " Validation of an elastic registration technique to estimate anatomical lung modification in NonSmall-Cell Lung Cancer Tomotherapy" docx
Ngày tải lên :
09/08/2014, 09:20
... left lung (patient 1). kVCT lung volume (full square), rigidly realigned MVCT lung volume (full
circle) and elastically registered MVCT lung volume(triangle). The rigid volume trend demonstrated ... significant
anatomical changes. In the cas e of Non-Small -Cell Lung
Cancer (NSCLC), lung parenchyma can significantly
modifyitsvolumeandshape[3].Asadirectconse-
quence, in lungs, dose discrepancies can oc cur between
the ... Access
Validation of an elastic registration technique to
estimate anatomical lung modification in Non-
Small -Cell Lung Cancer Tomotherapy
Elena Faggiano
1,2
, Giovanni M Cattaneo
3
, Cristina Ciavarro
4
,...
- 10
- 358
- 0
Báo cáo khoa học: "The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer" pdf
Ngày tải lên :
09/08/2014, 09:20
... limited -stage small -cell lung cancer. Int J Radiat Oncol Biol
Phys 2003, 56:355-359.
5. Roof KS, Fidias P, Lynch TJ, Choi NC: Radiation dose escalation in limited-
stage small -cell lung cancer. ... characteristics of
permanent human small cell lung cancer cell lines. J Cancer Res Clin
Oncol 1987, 113:31-40.
16. NCCN guidelines for small -cell lung cancer. [http://www.nccn.org/
professionals/physician_gls/f_guidelines.asp].
17. ... limited -stage small cell lung cancer. [http://
clinicaltrials.gov/ct2/show/NCT00433563].
27. Three different radiation therapy regimens in treating patients with
limited -stage small cell lung cancer...
- 9
- 465
- 0
Báo cáo hóa học: " Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer" pdf
Ngày tải lên :
18/06/2014, 16:20
... lung cancer patients.
Methods: EGFR mutation status was analyzed by DNA assays, and compared with IHC results in five non-small -cell
lung cancer (NSCLC) cell lines and tumor samples from 78 stage ... Non-small -cell lung cancer harbouring mutations in the EGFR
kinase domain. Clin Transl Oncol 2010, 12:75-80.
9. Gazdar AF: Activating and resistance mutations of EGFR in non-small -cell
lung cancer: ... mutations in lung cancer. Nat Rev Cancer 2007, 7:169-181.
3. Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T:
Mutations of the epidermal growth factor receptor gene in lung cancer:
biological...
- 8
- 798
- 0
Báo cáo khoa học: "Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size" ppsx
Ngày tải lên :
09/08/2014, 09:20
... non-small -cell lung
cancer. Int J Radiat Oncol Biol Phys 2002, 52:382-389.
16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapy
in treatment of stage I non-small cell lung cancer. ... stage IA patients and 9 among the stage IB
patients).
For all 124 patients, the overall survival (OAS) rate
was 71%, the cause-specific survival (CSS) rate was 87%,
and the progression-free survival ... for lung cancer varied greatly from
institution to institution [10]. The most frequently used
schedule was 48 Gy in 4 fractions for both stage IA and
IB primary lung cancer and metastatic lung cancer.
As...
- 7
- 297
- 0
Báo cáo khoa học: " Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer" docx
Ngày tải lên :
09/08/2014, 09:20
... Oligometastases, Non-Small Cell Lung Cancer
Background
Non-small cell lung cancer (NSCLC) is the leading
cause of cancer mortality in the United States [1].
Patients with stage IV NSCLC typically ... of 7
RESEARC H Open Access
Comparison of outcomes in patients with stage III
versus limited stage IV non-small cell lung cancer
Praveena Cheruvu
1
, Su K Metcalfe
1
, Justin Metcalfe
1
, Yuhchyau ... from 2000-2008. We identified 3 groups of patients with NSCLC: stage III, stage IV, and
recurrent stage IV (initial stage I-II). All stage IV NSCLC patients treated with SBRT had ≤ 8 lesions.
Results:...
- 7
- 368
- 0
Báo cáo khoa học: "Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study" pps
Ngày tải lên :
09/08/2014, 09:22
... surgery in patients with
operable lung cancer.
A randomized phase III trial of Radiosurgery Or Surgery
for operable Early stage (stage 1A) non-small cell Lung
cancer (ROSEL, ClinicalTrials.gov ... body radiotherapy for stage I
non-small cell lung cancer. Radiother Oncol 2007, 85:429-434.
39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-
eral primary lung cancers: the Indiana ... stereotactic
radiotherapy. Therefore, an additional planning study was
performed in 22 stage IA and 4 stage 1B non-small cell
lung cancer patients in order to develop and evaluate the
planning guidelines differentiated...
- 14
- 308
- 0
báo cáo hóa học:" Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer" docx
Ngày tải lên :
18/06/2014, 15:20
... Estimating the world cancer
burden: Globocan 2000. Int J Cancer 2001, 94:153-156.
2. Non-small Cell Lung Cancer Collaborative Group: Chemotherapy
in non small cell lung cancer: a meta-analysis ... docetaxel as first-line chemotherapy in
patients with advanced non-small cell lung cancer: a lung
cancer Galician group phase II study. Cancer Chemother Pharma-
col 2007, 60:725-732.
20. Binder D, Sailer ... cisplatin-teniposide in patients with
advanced non-small -cell lung cancer. The European Organi-
zation for Research and Treatment of Cancer Lung Cancer
Cooperative Group. J Clin Oncol 1998, 16:2133-2141.
7....
- 8
- 538
- 0
Báo cáo hóa học: "Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins" ppt
Ngày tải lên :
18/06/2014, 16:20
... often divided
into two broad categories: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). All major
histological types of lung cancer are associated with smoking, although ... act as a risk marker of lung cancer in Taiwan. Cancer 2003,
97:1558-1563.
11. Klein F, Amin Kotb WF, Petersen I: Incidence of human papilloma virus in
lung cancer. Lung Cancer 2009, 65:13-18.
12. ... HPVs in Asian lung
cancer is 35.7%. The authors concluded that HPV may
be the second leading cause of lung cancer after cigar-
ette smoking.
Although studies of viral-related lung cancer have
been...
- 11
- 471
- 0
Báo cáo hóa học: "Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization" pot
Ngày tải lên :
18/06/2014, 16:20
... marker expression in tumor cells versus stromal cells in non
small cell lung cancer. Clin Cancer Res 2007, 13:6649-57.
24. World Health Organization: Histological Typing of Lung and Pleural
Tumours. ... required for cancer
cell growth. PLoS One 2008, 3:e2557.
16. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular
profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006,
9:189-98.
17. ... NSCLC.
Introduction
Lung cancer is the leading cause of cancer- related mor-
tality in both men and women [1]. Despite several new
treatment achievements, the consistently poor 5-year
survival for lung cancer...
- 9
- 662
- 0
báo cáo hóa học: " Health state utilities for non small cell lung cancer" pot
Ngày tải lên :
18/06/2014, 19:20
... breast cancer. Br J Cancer 2006,
95(6):683-90.
17. Cancer Research UK [http://www.cancerresearchuk.org
]
18. Cancer Help [http://www.cancerhelp.org.uk
]
19. Association for International Cancer ... of small cell
and non-small cell lung cancer. University of Iowa Virtual Hos-
pital; 1999.
6. Hopwood P, Stephens RJ: Symptoms at presentation for treat-
ment in patients with lung cancer: Implications ... patients with either breast, colorectal or
NSCLC and in either early stages (stage I or II) or late
stages (stage III or IV) of cancer. All patients were either
receiving or had received chemotherapy...
- 15
- 397
- 0
Báo cáo toán học: "Molecular Predictors of EGFR-TKI Sensitivity in Advanced Non–small Cell Lung Cancer" ppsx
Ngày tải lên :
08/08/2014, 17:20
... gefitinib in non-small cell lung cancer
cell lines. Mol Cancer Res. 2006; 4(8): 521-8.
102. Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to
classify non-small -cell lung cancer patients ... non-small
cell lung cancer to long term survival. Br J Cancer. 1993; 68(1):
162-5.
87. Meert AP, Martin B, Delmotte P, et al. The role of EGF-R ex-
pression on patient survival in lung cancer: ... non-small
cell lung cancer Is correlated with survival. Clin Cancer Res.
2001; 7(7): 1850-5.
93. Cappuzzo F, Gregorc V, Rossi E, et al. Gefitinib in pretreated
non-small -cell lung cancer (NSCLC):...
- 9
- 203
- 0
Báo cáo khoa học: "Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer" pptx
Ngày tải lên :
09/08/2014, 03:21
... diagnosis, with a 5-
year survival of 20-30%, the majority of patients with
stage IIIA-N2 and IIIB-N2 tumors cannot undergo up-
front surgical resection and present a 5-year survival
rate of about 5%[1]. ... Carteni’
1
Abstract
Background: Defining the optimal treatment for patients with inoperable non small cell lung cancer (NSCLC),
presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless, ... cycles should not
automatically discourage to continue treatment.
Introduction
In non-small cell lung cancer (NSCLC), mediastinal
lymphnode involvement comprises a wide spectrum of
severity. In...
- 4
- 303
- 0
Báo cáo khoa học: "Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy" pot
Ngày tải lên :
09/08/2014, 08:23
... limited
stage small cell lung cancer. Int J Radiat Oncol Biol Phys 1999, 43:39-45.
31. Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM: Factors
predicting radiation pneumonitis in lung ... unresectable locally advanced non-
small cell lung cancer (NSCLC). Unfortunately, the longer
survival is achieved at the price of greater toxicity of the
lung and the esophageal mucosa [3-5].
* ... Komaki R, Mohan R:
Dose and volume reduction for normal lung using intensity-
modulated radiotherapy for advanced -stage non-small -cell lung
cancer. Int J Radiat Oncol Biol Phys 2004, 58:1258-1267.
21....
- 8
- 371
- 0